Results 101 to 110 of about 5,803 (182)

A new analytical method for determination of ledipasvir and sofosbuvir in pharmaceutical formulations by HPLC method

A simple, Accurate, precise method was developed for the simultaneous estimation of the Sofosbuvir and Ledipasvir in Tablet dosage form. Chromatogram was run through Std Discovery C8 150 x 4.6 mm, 5m. Mobile phase containing Buffer 0.1% OPA: Acetonitrile
K, Swathi, P, Venkateswara Rao, N, Srinivasa Rao   +2 more
core  

Treatment of Chronic Hepatitis C Virus Infection With Crushed Ledipasvir/Sofosbuvir Administered via a Percutaneous Endoscopic Gastrostomy Tube

, 2017
Introduction: Ledipasvir/sofosbuvir (Harvoni®) is a fixed-dose tablet indicated for the treatment of chronic hepatitis C virus (HCV) infection. There are currently no data available on the safety and efficacy of crushed ledipasvir/sofosbuvir tablets ...
Jennifer Stark, Lauren Jindracek
core   +1 more source

Rhabdomyolysis and pancytopenia secondary to an unexpected interaction between ledipasvir/sofosbuvir, atorvastatin and colchicine

, 2017
Case Presentation: A 65-year-old woman with hepatitis C-induced liver cirrhosis status-post liver transplantation, coronary artery disease and gout, presents with one week of progressive fatigue, weakness, and severe pain in her right leg and left ...
Cerasale, Matthew, Gildeh, Edward
core   +1 more source

Effectiveness of 8- or 12-weeks of ledipasvir and sofosbuvir in real-world treatment-naïve, genotype 1 hepatitis C infected patients.

, 2017
BACKGROUND: Treatment of genotype 1 hepatitis C virus (HCV) infection with combination direct acting anti-virals is associated with very high rates of sustained virological response (SVR).
Kowdley, K V, Curry, M P, Bacon, B, Tsai, N, Afdhal, N H, Tapper, E B, Dieterich, D, Younossi, Z, Lee, Y, Flamm, S L, Milligan, S, Guest, L   +11 more
core  

Human Pegivirus Encephalitis With Brain Detection and Response to Sofosbuvir Ledipasvir. [PDF]

Ann Clin Transl Neurol
Moulignier A, Heran F, Lallemand F, Bourdillon P.   +3 more
europepmc   +1 more source

Multi-Target Inhibition of F10/F2/PAR1 Through In Silico Drug Repurposing of Avodart and Naldemedine to Prevent Thrombotic-Induced Sudden Cardiac Arrest. [PDF]

Biomedicines
Al-Subaie AM, AbdulAzeez S.
europepmc   +1 more source

Increasing competition in pharmaceutical tenders: Patents, treatment guidelines, and centralised procurement of Hepatitis C drugs in Brazil. [PDF]

Glob Public Health
Mercadante E.
europepmc   +1 more source

Ledipasvir/sofosbuvir combination for chronic hepatitis C infection in children and adolescents Combinación de ledipasvir/sofosbuvir como tratamiento de la infección crónica por hepatitis C

Càrrega feta de Scopus d'articles UAB 2019 (Gold, hybrid o Bronze) procedents de l'Observatori d'Accés Obert (càrrega maig 2020). Compte! Cal comprovar la versió permesa per l'editor en els bronze.Introduction: Hepatitis C virus infection is world health
Segarra, Ó., Rodrigo Gonzalo de Líria, Carlos, Juampérez, J., Julio, E., Mercadal-Hally, M., Quintero, J., Universitat Autònoma de Barcelona, Soler-Palacín, P., Cabello, V.   +8 more
core  

Nationwide Socioeconomic Evaluation of Direct-Acting Antivirals for Chronic Hepatitis C Virus Infection in Japan Between 2014 and 2023. [PDF]

J Viral Hepat
Suoh M, Esmaili S, Eslam M, George J.
europepmc   +1 more source

Repurposing antiviral drugs targeting RNA viruses: A focus on the fusion protein of human metapneumovirus. [PDF]

North Clin Istanb
Aras M, Yayintas OT.
europepmc   +1 more source